OrganOx

Oxford University spin-out OrganOx, a pioneering transplant technology company, has been acquired by Japanese medical devices group Terumo in a significant $1.5 billion (£1.2 billion) transaction, marking one of the largest ever deals for a UK medical technology business.

Summary of transaction details:

• Value: £1.2 billion ($1.5 billion)
• Sector: Healthcare & Biotech (Transplant Technology)
• Advisor: Not specified
• Key Entities: OrganOx (Target), Terumo (Acquirer), Oxford University (Founder/Shareholder), BGF (Investor/Shareholder)
• Location: OrganOx (UK - Oxford), Terumo (Japan - Tokyo)

Note: This acquisition underscores the global demand for advanced medical technologies developed in the UK while also raising discussions about the long-term retention of successful British spin-outs within domestic ownership. Terumo plans to leverage OrganOx's technology to expand its presence in the organ transplantation market globally.